Group 1 - The flu concept sector experienced a decline of 1.41%, ranking among the top declines in concept sectors, with companies like Qizheng Pharmaceutical and Hanyu Pharmaceutical seeing significant drops [1][2] - Among the 22 stocks that rose, Hotgen Biotech, Borui Pharmaceutical, and Chenxin Pharmaceutical led with increases of 10.97%, 9.96%, and 8.16% respectively [1][2][8] Group 2 - The flu concept sector saw a net outflow of 3.988 billion yuan, with 137 stocks experiencing net outflows, and 7 stocks seeing outflows exceeding 100 million yuan [2] - Hanyu Pharmaceutical had the highest net outflow of 256 million yuan, followed by Tonghua Jinma and Zhendong Pharmaceutical with outflows of 159 million yuan and 153 million yuan respectively [2][3] - Stocks with the highest net inflows included Borui Pharmaceutical, Chenxin Pharmaceutical, and Xiangrikui, with inflows of 222 million yuan, 121 million yuan, and 3.468 million yuan respectively [2][8]
流感概念下跌1.41%,主力资金净流出137股